Skip to content
Axe Capital logo Axe Capital Trading News

This Aerospace Stock Is Cheap, But Does That Make It a Buy Today?

2026-08-01 17:15 Reuben Gregg Brewer The Motley Fool Neutral Axe Cap view: Neutral EquitiesM&A ACHRACHR.WS

Axe Cap view

Why Cheap Aerospace Stocks Don’t Always Mean Buy

Archer Aviation’s sharp fall reflects regulatory and production hurdles that keep this stock out of reach for most investors.

Archer Aviation’s shares have dropped more than 60% since 2025, now trading close to the levels seen during its SPAC merger in 2021. The company’s eVTOL aircraft—electric vertical takeoff and landing—do look exciting, targeting urban air mobility with its Midnight model and industrial use with Thunder. Still, the reality is that these flying taxi dreams aren’t flying off the shelves yet. Regulatory approval is a major unknown, production has not scaled, and the competition in this space shows no mercy. Given these risks, any gains seem a long way off. For South African investors, there’s no direct listed equivalent to ride this wave locally. Instead, the state of this kind of futuristic tech often nudges the USD/ZAR higher when risk appetite dips, as speculative plays out of reach push capital back into safer assets. Selling pressure on such stocks tends to drag the rand weaker. Investors should watch and wait until we see concrete commercial rollouts before jumping in. this is just our opinion and not financial advice

How I would invest

Avoid Archer Aviation for now given the regulatory and execution risks. Look instead at stable JSE staples or hold cash for when clearer catalysts emerge.

What I would watch
  • ACHR
  • USD/ZAR
What could go wrong
  • Regulatory delays or failures
  • Production cost overruns
  • Stronger-than-expected competition
How strongly I feel

6/10

Archer Aviation's stock has fallen over 60% from 2025 highs and now trades near 2021 SPAC merger levels. While the company is developing promising eVTOL aircraft (Midnight for commercial use, Thunder for military/industrial applications), significant challenges remain including ongoing losses, pending regulatory approvals, production ramp-up costs, and intense competition. Most investors should wait for commercial approval before considering a purchase.

Our take is based on reporting first published by The Motley Fool.

Read the original story